Who owns JNJWhat JNJ owns
What JOHNSON & JOHNSON owns
The company's own 13F portfolio · as of 2026-06-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$798.7M
disclosed stock portfolio
15
positions
37.6%
in PTGX
Positions, as of 2026-06-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PTGXPROTAGONIST THERAPEUTICS INC | 2.4M | $300.2M | 37.6% |
| 2 | NBTXNANOBIOTIX | 5.6M | $212.0M | 26.5% |
| 3 | MGTXMEIRAGTX HLDGS PLC | 6.6M | $89.7M | 11.2% |
| 4 | RAPPRAPPORT THERAPEUTICS INC | 1.8M | $74.4M | 9.3% |
| 5 | CTNMCONTINEUM THERAPEUTICS INC | 2.0M | $32.4M | 4.1% |
| 6 | LEGNLEGEND BIOTECH CORP | 814,586 | $23.5M | 2.9% |
| 7 | CVRXCVRX INC | 4.0M | $20.7M | 2.6% |
| 8 | XNCRXENCOR INC | 748,062 | $12.0M | 1.5% |
| 9 | CBRSCEREBRAS SYSTEMS INC | 53,586 | $11.8M | 1.5% |
| 10 | FATEFATE THERAPEUTICS INC | 3.4M | $9.1M | 1.1% |
| 11 | PRCTPROCEPT BIOROBOTICS CORP | 357,939 | $8.1M | 1% |
| 12 | NMRANEUMORA THERAPEUTICS INC. | 1.8M | $3.1M | 0.4% |
| 13 | VORVOR BIOPHARMA INC | 53,732 | $989,206 | 0.1% |
| 14 | LABSTANDARD BIOTOOLS INC | 311,967 | $256,655 | 0% |
| 15 | ACETADICET BIO INC | 22,779 | $196,811 | 0% |
Source: SEC Form 13F-HR filed by JOHNSON & JOHNSON (CIK 200406), reporting period 2026-06-30. Values are quarter-end filed marks. Research, not investment advice.